首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Drug development research

缩写:DRUG DEVELOP RES

ISSN:0272-4391

e-ISSN:1098-2299

IF/分区:4.2/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1324
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Bing Wei,Yan Zhang,Lixia Tang et al. Bing Wei et al.
Hit, Lead & Candidate Discovery This study investigated the effects of a natural phenolic compound quercetin on surgical-induced osteoarthritis (OA) in rabbits. Forty-eight New Zealand White rabbits were used to establish OA model by Hulth ...
Govindaraj Saravanan,Theivendren Panneerselvam,Selvaraj Kunjiappan et al. Govindaraj Saravanan et al.
Hit, Lead & Candidate Discovery A variety of novel 2-(methyl/phenyl)-3-(4-(5-substituted-1,3,4-oxadiazol-2-yl)phenyl) quinazolin-4(3H)-ones have been synthesized by treating 3-(4-(5-mercapto-1,3,4-oxadiazol-2-yl)phenyl)-2-(methyl/phenyl)-qu...
Hamid Madanchi,Shabnam Akbari,Ali Akbar Shabani et al. Hamid Madanchi et al.
Considering the worldwide increasing prevalence of resistance to traditional antibiotics, it is necessary to find new antibiotics to deal with this issue. Recently, antimicrobial peptides (AMPs) have been proposed as new antimicrobial agent...
David Cáceres-Castillo,Yussel Pérez-Navarro,Julio César Torres-Romero et al. David Cáceres-Castillo et al.
Trichomoniasis, caused by the protozoan parasite Trichomonas vaginalis, is the most common nonviral sexually transmitted infection worldwide. Although drug treatment is available, unpleasant side effects and increased resistance to the nitr...
Aya A M Mohammed,Ghadeer A R Y Suaifan,Mayadah B Shehadeh et al. Aya A M Mohammed et al.
In the quest for discovering potent antimicrobial agents with lower toxicity, we envisioned the design and synthesis of nalidixic acid-D-(+)-glucosamine conjugates. The novel compounds were synthesized and evaluated for their in vitro antim...
Hend Kothayer,Samy M Ibrahim,Moustafa K Soltan et al. Hend Kothayer et al.
In light of the pharmacophoric structural requirements for achieving anticonvulsant activity, a series of N-(1-methyl-4-oxo-2-un/substituted-1,2-dihydroquinazolin-3[4H]-yl)benzamide (4a-g) and N-(1-methyl-4-oxo-2-un/substituted-1,2-dihydroq...
Saima,Isha Soni,Aditya G Lavekar et al. Saima et al.
Staphylococcus aureus is a WHO Priority II pathogen for its capability to cause acute to chronic infections and to resist antibiotics, thus severely impacting healthcare systems worldwide. In this context, it is urgently desired to discover...
Nermin S Ahmed Nermin S Ahmed
Hit, Lead & Candidate Discovery Tadalafil, Cialis, Eli Lilly & Co./ICOS, (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6] pyrido[3,4-b]indole-1,4-dione, was first discovered in 2003. It was reported to...
Yang Li,Feng Sun,Wenhong Zhang Yang Li
Improving treatment outcomes in multidrug-resistant tuberculosis (MDR-TB) is partly hampered by inadequate effective antitubercular agents. Development of bedaquiline and delamanid has potentially changed the treatment landscape for MDR-TB....